EUCTR2006-000995-33-NL进行中（未招募）1 期
EuroNet-Paediatric Hodgkin?s Lymphoma Group First international Inter-Group Study for classical Hodgkin?s Lymphoma in Children and Adolescents - EuroNet-PHL-C1
Martin-Luther-University Halle-Wittenberg0 个研究点目标入组 1,200 人开始时间: 2010年9月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •?diagnosis of classic Hodgkin?s lymphoma
- •?patient aged under 18 years at time of diagnosis
- •?written informed consent of the patient and/or the patient?s parents or guardian according to national laws
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •?pre-treatment of Hodgkin?s lymphoma differing from study protocol (except recommended pre-phase therapy of a large mediastinal tumour)
- •?known hypersensitivity or contraindication to study drugs
- •?diagnosis of lymphocyte predominant Hodgkin?s lymphoma
- •?prior chemotherapy or radiotherapy
- •?other (simultaneous) malignancies
- •?pregnancy and / or lactation
- •?females who are sexually active refusing to use effective contraception (oral contraception, intrauterine devices, barrier method of contraception in conjunction with spermicidal jelly or surgical sterile)
- •?Current or recent (within 30 days prior to start of trial treatment) treatment with another investigational drug or participation in another investigational trial
- •?severe concomitant diseases (e.g. immune deficiency syndrome)
- •?known HIV positivity
研究者
相似试验
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Study for classical Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-C1EUCTR2006-000995-33-DKMartin-Luther-University Halle-Wittenberg25
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group Second trial conducted by European experts in the field for treating Classical Hodgkin’s Lymphoma in Children and AdolescentsHodgkin lymphoma in children and adolescentsEUCTR2012-004053-88-SEJustus-Liebig-University Giessen2,200
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Study for classical Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-C11st and 2nd line therapy for childhood Hodgkin’s lymphoma shall be further optimised to avoid over-treatment and decrease long-term complications.MedDRA version: 8.1 Level: HLGT Classification code 10025319 Term: Lymphomas Hodgkin's diseaseEUCTR2006-000995-33-DEMartin-Luther-University Halle-Wittenberg1,200
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin?s Lymphoma Group First international Inter-Group Studyfor nodular lymphocyte-predominant Hodgkin?s Lymphoma in Children and Adolescents - EuroNet-PHL-LP1EUCTR2007-004092-19-NLMartin Luther University of Halle/Wittenberg
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Studyfor nodular lymphocyte-predominant Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-LP1The first line therapy for childhood nodular lymphocyte-predominant Hodgkin’s lymphoma shall be further optimised to avoid over-treatment and decrease long-term complications.EUCTR2007-004092-19-CZMartin Luther University of Halle/Wittenberg250